A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C

Clinical trial NCT05163288 · RECRUITING

Trial details

NCT number: NCT05163288
Sponsor: IntraBio Inc
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Niemann-Pick Disease, Type C

Start date: 2022-06-30
Primary completion: 2030-06-12
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.